We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00483795
First Posted: June 7, 2007
Last Update Posted: July 25, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Innovative Medical
  Purpose
To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.

Condition Intervention Phase
Corneal Staining Drug: sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single

Resource links provided by NLM:


Further study details as provided by Innovative Medical:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • Patients 18 yrs or older
  • Males or females
  • Any race or ethnic background
  • CL patients using (multipurpose solutions) MPS
  • Patients using Acuvue 2 lenses

Exclusion Criteria:

  • Corneal refractive surgery within 6 months of this study.
  • Contact lens use on day of examination.
  • Corneal ectasia.
  • Current use of Restasis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00483795


Locations
United States, Pennsylvania
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States, 18202
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Thomas Kislan, OD Hazleton Eye Specialists
  More Information

ClinicalTrials.gov Identifier: NCT00483795     History of Changes
Other Study ID Numbers: 5308
First Submitted: June 1, 2007
First Posted: June 7, 2007
Last Update Posted: July 25, 2007
Last Verified: July 2007

Additional relevant MeSH terms:
Citric Acid
Anticoagulants
Calcium Chelating Agents
Chelating Agents
Sequestering Agents
Molecular Mechanisms of Pharmacological Action